Gopinadhan N Anilkumar

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 12 (Patent Applications = 6)

Average Co-Inventor Count = 9.1

ph-index = 7

Forward Citations = 97(Granted Patents)

Company Filing History:

Pharmacopeia Drug Discovery, Inc.

patents

4 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2008-2013

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8614229 - Substituted indole derivatives and methods of use thereof (2013-12-24),

2. 8557848 - 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-15),

3. 8546420 - 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-01),

4. 8404845 - 2,3-substituted azaindole derivatives for treating viral infections (2013-03-26),

5. 8207170 - Heterocyclic substituted piperazines with CXCR3 antagonist activity (2012-06-26),

6. 8143305 - 2,3-substituted indole derivatives for treating viral infections (2012-03-27),

7. 7879838 - Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity (2011-02-01),

8. 7868006 - Heterocyclic substituted piperazines with CXCR3 antagonist activity (2011-01-11),

9. 7868005 - Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity (2011-01-11),

10. 7799789 - Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity (2010-09-21),

11. 7776862 - Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity (2010-08-17),

12. 7763616 - Piperazine-piperidines with CXCR3 antagonist activity (2010-07-27),

13. 7417045 - Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity (2008-08-26),

Title: Innovator Spotlight: Gopinadhan N Anilkumar

Introduction: Gopinadhan N Anilkumar is a distinguished inventor based in Edison, NJ, whose contributions to the field of pharmaceuticals have resulted in a remarkable portfolio of 13 patents. Her innovative work primarily focuses on developing novel compounds for treating viral infections, showcasing her commitment to addressing critical health challenges.

Latest Patents: Among her latest patents are two notable inventions. The first, titled "Substituted Indole Derivatives and Methods of Use Thereof," relates to substituted indole derivatives and their compositions for treating or preventing viral infections and virus-related disorders in patients. The second patent, "4,5-Ring Annulated Indole Derivatives for Treating or Preventing HCV and Related Viral Infections," introduces 4,5-ring annulated indole derivatives that also aim to combat viral infections and their complications. These innovations underscore her expertise in medicinal chemistry and the potential therapeutic applications of her research.

Career Highlights: Gopinadhan has had an impactful career, having contributed her talents to leading organizations such as Schering Corporation and Pharmacopeia Drug Discovery, Inc. Her work within these companies has been instrumental in advancing the field of drug discovery and development.

Collaborations: Throughout her career, Gopinadhan has collaborated with esteemed colleagues, including Stuart B. Rosenblum and Joseph A. Kozlowski. These partnerships reflect a collaborative spirit in research and innovation, further enriching her contributions to science and medicine.

Conclusion: Gopinadhan N Anilkumar exemplifies the drive and creativity inherent in the field of invention. Her patents not only highlight her innovative spirit but also represent significant advancements in the treatment of viral infections. As she continues her work, her contributions will undoubtedly play a vital role in shaping future therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.